<?xml version="1.0" encoding="UTF-8" ?>
<modsCollection xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" xmlns:slims="http://senayan.diknas.go.id" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd">
<mods version="3.3" ID="2362">
<titleInfo>
<title>European Journal of Pharmaceutical Sciences 1 May 2025</title>
</titleInfo>
<typeOfResource manuscript="yes" collection="yes">mixed material</typeOfResource>
<genre authority="marcgt">bibliography</genre>
<originInfo>
<place><placeTerm type="text"></placeTerm></place>
<publisher></publisher>
<dateIssued>2025</dateIssued>
<issuance>monographic</issuance>
<edition>1 May 2025</edition>
</originInfo>
<language>
<languageTerm type="code">id</languageTerm>
<languageTerm type="text">Indonesia</languageTerm>
</language>
<physicalDescription>
<form authority="gmd">Jurnal</form>
<extent></extent>
</physicalDescription>
<note>ABSTRACT
Cannabidiol (CBD), one of the main actives from Cannabis sativa has been perpetually explored lately for its
therapeutic effects. Its main attributes, such as anti-inflammatory and antioxidant effects, snowball into pain
management, epilepsy and seizure alleviation, anxiety relief, as well as numerous other implications through the

entire metabolism. However, conventional administration routes challenge its therapeutic potential, with re-
ported poor water solubility, hepatic degradation, gastric instability and erratic bioavailability observed in oral

administration. As a result, the transdermal delivery systems have emerged as a promising alternative to oral or
inhaled routes, offering improved bioavailability and targeted effects. The medical use of CBD throughout
Europe, UK, USA or Australia is extensive and usually represented by pharmaceutical preparations recommended
after conventional treatment routs fail. The non-medical use is limited by each country&rsquo;s own legislation, a wider
range of products being available, but the irregular regulatory landscape coupled with the growing market of
cannabinoid-infused products, emphasizes the need for standardized formulations and further clinical research.
The present work critically examines the transdermal administration of cannabidiol, explores the skin&rsquo;s potential
as a route and the strategies involved in using it for systemic targeting. We highlighted key challenges and
provided insights into CBD`s variable bioavailability based on different administration routes and methods, thus
compiling a literature-based absorption, distribution, metabolism, and excretion (ADME) study. We also explore
the role of the endocannabinoid system, its function in various medical conditions, and the therapeutic effects

associated with CBD, particularly in light of the varying legislation across countries. While the breadth of po-tential benefits is compelling, it is essential to emphasize the ongoing nature of CBD research as individual re-sponses to it can vary significantly.</note>
<subject authority=""><topic>Cannabis policies</topic></subject>
<subject authority=""><topic>Transdermal drug delivery</topic></subject>
<subject authority=""><topic>Cannabidiol</topic></subject>
<classification></classification><identifier type="isbn"></identifier><location>
<physicalLocation>PERPUSTAKAAN SEKOLAH TINGGI ILMU KESEHATAN SAMARINDA REPOSITORY</physicalLocation>
<shelfLocator></shelfLocator>
<holdingSimple>
<copyInformation>
<numerationAndChronology type="1">JIN0145</numerationAndChronology>
<sublocation>Perpus.Akfarsam (Jurnal Farmasi Internasional)</sublocation>
<shelfLocator>615 ASI</shelfLocator>
</copyInformation>
</holdingSimple>
</location>
<slims:digitals>
<slims:digital_item id="2235" url="https://drive.google.com/file/d/1vUECVYW_vfopZKCJPAgK_-3gpy6hQDFq/view?usp=sharing" path="/https://drive.google.com/file/d/1vUECVYW_vfopZKCJPAgK_-3gpy6hQDFq/view?usp=sharing" mimetype="text/uri-list">1 May 2025</slims:digital_item>
</slims:digitals><slims:image>1_May_2025.jpeg.jpeg</slims:image>
<recordInfo>
<recordIdentifier>2362</recordIdentifier>
<recordCreationDate encoding="w3cdtf">2026-07-14 08:10:29</recordCreationDate>
<recordChangeDate encoding="w3cdtf">2026-07-14 08:34:55</recordChangeDate>
<recordOrigin>machine generated</recordOrigin>
</recordInfo></mods></modsCollection>